These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9139325)

  • 21. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
    Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and HIV infection: impact on immune function and disease progression.
    Cruess DG; Petitto JM; Leserman J; Douglas SD; Gettes DR; Ten Have TR; Evans DL
    CNS Spectr; 2003 Jan; 8(1):52-8. PubMed ID: 12627049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimistic explanatory style and dispositional optimism in HIV-infected men.
    Tomakowsky J; Lumley MA; Markowitz N; Frank C
    J Psychosom Res; 2001 Oct; 51(4):577-87. PubMed ID: 11595246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in persons living with HIV.
    Eller LS
    Clin Nurs Res; 2001 Nov; 10(4):401-23. PubMed ID: 11881951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of partial variance (APV) as a statistical approach to control day to day variation in immune assays.
    Schleifer SJ; Eckholdt HM; Cohen J; Keller SE
    Brain Behav Immun; 1993 Sep; 7(3):243-52. PubMed ID: 8106022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group.
    Patterson TL; Semple SJ; Temoshok LR; Atkinson JH; McCutchan JA; Straits-Tröster K; Chandler JL; Grant I
    Psychiatry; 1995 Nov; 58(4):299-312. PubMed ID: 8746489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression and HIV. A nursing perspective on a complex relationship.
    McEnany GW; Hughes AM; Lee KA
    Nurs Clin North Am; 1996 Mar; 31(1):57-80. PubMed ID: 8604387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoneuroimmunology and HIV infection.
    Gorman JM; Kertzner R
    J Neuropsychiatry Clin Neurosci; 1990; 2(3):241-52. PubMed ID: 2136081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A behavioral medicine intervention in persons with HIV.
    Nicholas PK; Webster A
    Clin Nurs Res; 1996 Nov; 5(4):391-406. PubMed ID: 8970278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression in HIV-infected persons.
    Boland RJ
    Psychosomatics; 1998; 39(1):82-3. PubMed ID: 9538682
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective associations between lateralised brain function and immune status in HIV infection: analysis of EEG, cognition and mood over 30 months.
    Gruzelier J; Burgess A; Baldeweg T; Riccio M; Hawkins D; Stygall J; Catt S; Irving G; Catalan J
    Int J Psychophysiol; 1996 Oct; 23(3):215-24. PubMed ID: 8947787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An interdisciplinary research model to investigate psychosocial cofactors in disease: Application to HIV-1 pathogenesis.
    Kemeny ME
    Brain Behav Immun; 2003 Feb; 17 Suppl 1():S62-72. PubMed ID: 12615189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reference range of CD4+ and CD8+ T-lymphocytes in healthy non-infected infants born to HIV-1 seropositive mothers; a preliminary study at Siriraj Hospital.
    Likanonsakul S; Wasi C; Thepthai C; Sutthent R; Louisirirotchanakul S; Chearskul S; Vanprapa N; Lebnark T
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):453-63. PubMed ID: 10437939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of clinical and laboratory surrogate markers of immunodepletion with T cell subsets (CD4 & CD8) determined flow cytometrically in HIV infected patients: a hospital based study.
    Uppal SS; Gupta S; Verma S
    J Commun Dis; 2003 Sep; 35(3):140-53. PubMed ID: 15796406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Depressive affect and surrogate markers in HIV infected patients].
    Brauchli P; Zeier H
    Psychother Psychosom Med Psychol; 1997 Jan; 47(1):34-40. PubMed ID: 9139325
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.